Home › Trial NCT03361735
Radium Ra 223 Dichloride, Hormone Therapy and Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Prostate Cancer
- Trial IDNCT03361735
- StatusActive Not Recruiting
- PhasePhase 2
- Study typeInterventional
- SponsorCity of Hope Medical Center
- Enrollment25
- Start date2018-08-29
- ConditionsProstate Adenocarcinoma
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.